Literature DB >> 20060285

Breast cancer genomes--form and function.

James Korkola1, Joe W Gray.   

Abstract

This review summarizes advances in our understanding of the genomic and epigenomic abnormalities in breast cancers that are being revealed by the increasingly powerful suite of genomic analysis technologies. It summarizes the remarkable genomic heterogeneity that characterizes the disease, describes mechanisms that shape cancer genomes as they evolve toward metastasis, summarizes important recurrent aberrations that exist in spite of the genomic chaos and that contribute to breast cancer pathophysiology, and describes the use of preclinical models to identify drugs that will be effective against subsets of breast cancers carrying specific genomic and epigenomic abnormalities. Copyright 2009. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20060285      PMCID: PMC2956580          DOI: 10.1016/j.gde.2009.11.005

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  97 in total

1.  Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.

Authors:  Lodewyk F A Wessels; Tibor van Welsem; Augustinus A M Hart; Laura J van't Veer; Marcel J T Reinders; Petra M Nederlof
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

Review 2.  The state-of-the-art of chromatin immunoprecipitation.

Authors:  Philippe Collas
Journal:  Methods Mol Biol       Date:  2009

3.  The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis.

Authors:  M D Sternlicht; A Lochter; C J Sympson; B Huey; J P Rougier; J W Gray; D Pinkel; M J Bissell; Z Werb
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

4.  c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers.

Authors:  Kyeongmee Park; Keumhee Kwak; Jungyeon Kim; Sungjig Lim; Sehwan Han
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

Review 5.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

6.  Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.

Authors:  G D Lewis; J A Lofgren; A E McMurtrey; A Nuijens; B M Fendly; K D Bauer; M X Sliwkowski
Journal:  Cancer Res       Date:  1996-03-15       Impact factor: 12.701

7.  Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program.

Authors:  Yongping G Crawford; Mona L Gauthier; Anita Joubel; Kristin Mantei; Krystyna Kozakiewicz; Cynthia A Afshari; Thea D Tlsty
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

8.  A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition.

Authors:  Neil E Torbett; Antonio Luna-Moran; Zachary A Knight; Andrew Houk; Mark Moasser; William Weiss; Kevan M Shokat; David Stokoe
Journal:  Biochem J       Date:  2008-10-01       Impact factor: 3.857

9.  Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Authors:  Philippe Bertheau; Elisabeth Turpin; David S Rickman; Marc Espié; Aurélien de Reyniès; Jean-Paul Feugeas; Louis-François Plassa; Hany Soliman; Mariana Varna; Anne de Roquancourt; Jacqueline Lehmann-Che; Yves Beuzard; Michel Marty; Jean-Louis Misset; Anne Janin; Hugues de Thé
Journal:  PLoS Med       Date:  2007-03       Impact factor: 11.069

10.  Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.

Authors:  Jason I Herschkowitz; Karl Simin; Victor J Weigman; Igor Mikaelian; Jerry Usary; Zhiyuan Hu; Karen E Rasmussen; Laundette P Jones; Shahin Assefnia; Subhashini Chandrasekharan; Michael G Backlund; Yuzhi Yin; Andrey I Khramtsov; Roy Bastein; John Quackenbush; Robert I Glazer; Powel H Brown; Jeffrey E Green; Levy Kopelovich; Priscilla A Furth; Juan P Palazzo; Olufunmilayo I Olopade; Philip S Bernard; Gary A Churchill; Terry Van Dyke; Charles M Perou
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  12 in total

1.  Lectin chromatography/mass spectrometry discovery workflow identifies putative biomarkers of aggressive breast cancers.

Authors:  Penelope M Drake; Birgit Schilling; Richard K Niles; Akraporn Prakobphol; Bensheng Li; Kwanyoung Jung; Wonryeon Cho; Miles Braten; Halina D Inerowicz; Katherine Williams; Matthew Albertolle; Jason M Held; Demetris Iacovides; Dylan J Sorensen; Obi L Griffith; Eric Johansen; Anna M Zawadzka; Michael P Cusack; Simon Allen; Matthew Gormley; Steven C Hall; H Ewa Witkowska; Joe W Gray; Fred Regnier; Bradford W Gibson; Susan J Fisher
Journal:  J Proteome Res       Date:  2012-03-13       Impact factor: 4.466

2.  Personalized medicine and tobacco-related health disparities: is there a role for genetics?

Authors:  Chris Carlsten; Abigail Halperin; Julia Crouch; Wylie Burke
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

3.  Proteomic studies in breast cancer (Review).

Authors:  Xian-Ju Qin; Bruce X Ling
Journal:  Oncol Lett       Date:  2012-01-18       Impact factor: 2.967

Review 4.  Breast cancer - one term, many entities?

Authors:  Nicholas R Bertos; Morag Park
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

5.  Early G₁ cyclin-dependent kinases as prognostic markers and potential therapeutic targets in esophageal adenocarcinoma.

Authors:  Amin Ismail; Santhoshi Bandla; Marie Reveiller; Liana Toia; Zhongren Zhou; William E Gooding; Irina Kalatskaya; Lincoln Stein; Mary D'Souza; Virginia R Litle; Jeffrey H Peters; Arjun Pennathur; James D Luketich; Tony E Godfrey
Journal:  Clin Cancer Res       Date:  2011-05-18       Impact factor: 12.531

Review 6.  Characterizing complex structural variation in germline and somatic genomes.

Authors:  Aaron R Quinlan; Ira M Hall
Journal:  Trends Genet       Date:  2011-11-15       Impact factor: 11.639

7.  Bioinformatics tools for cancer metabolomics.

Authors:  Grigoriy Blekherman; Reinhard Laubenbacher; Diego F Cortes; Pedro Mendes; Frank M Torti; Steven Akman; Suzy V Torti; Vladimir Shulaev
Journal:  Metabolomics       Date:  2011-01-12       Impact factor: 4.290

8.  DNA damage response markers are differentially expressed in BRCA-mutated breast cancers.

Authors:  Mohammed Aleskandarany; Daniela Caracappa; Christopher C Nolan; R Douglas Macmillan; Ian O Ellis; Emad A Rakha; Andrew R Green
Journal:  Breast Cancer Res Treat       Date:  2015-02-19       Impact factor: 4.872

9.  Genetic Association of rs2237572 Cyclin-Dependent Kinase 6 Gene with Breast Cancer in Iraq.

Authors:  Dalya Sh Al-Owaidi; Moaed E Algazally; Alaa Sadeq Alawaad
Journal:  Indian J Clin Biochem       Date:  2020-06-08

Review 10.  Cat Mammary Tumors: Genetic Models for the Human Counterpart.

Authors:  Filomena Adega; Ana Borges; Raquel Chaves
Journal:  Vet Sci       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.